Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial
Alex F. Herrera, Lu Chen, Yago Nieto, Leona Holmberg, Patrick B. Johnston, Matthew Mei, Leslie Popplewell, Saro H. Armenian, Thai M. Cao, Leonardo Farol, Firoozeh Sahebi, Ricardo Spielberger, Robert Chen, Auayporn Nademanee, Sandrine Puverel, Mary Nwangwu, Peter Lee, Joo Y. Song, Alan P Skarbnik, Neena Kennedy, Lacolle Peters, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Tatyana Feldman
Topics & Concepts
Brentuximab vedotinMedicineInternal medicineNivolumabOncologyTransplantationHematopoietic stem cell transplantationAutologous stem-cell transplantationSurgeryLymphomaHodgkin lymphomaCancerImmunotherapyLymphoma Diagnosis and TreatmentCAR-T cell therapy researchCutaneous lymphoproliferative disorders research